# HCLS1

## Overview
HCLS1, or hematopoietic cell-specific Lyn substrate 1, is a gene that encodes the HS1 protein, an actin-binding protein predominantly expressed in hematopoietic cells. The HS1 protein plays a pivotal role in the regulation of actin dynamics, which are crucial for various cellular processes such as adhesion, migration, and immune cell activation. Structurally, HS1 is characterized by several functional domains, including an N-terminal acidic region, a coiled-coil domain, and a C-terminal SH3 domain, which facilitate its interactions with other proteins and its involvement in cellular signaling pathways (Muzio2007HS1; CastroOchoa2018Hematopoietic). HS1 is particularly significant in immune cell function, participating in T and B cell receptor signaling and natural killer cell activity. Its phosphorylation by kinases such as Syk and Lyn is essential for its role in these processes (CastroOchoa2018Hematopoietic). Clinically, alterations in HCLS1 expression and function have been associated with various diseases, including chronic lymphocytic leukemia and systemic lupus erythematosus, highlighting its potential as a biomarker and therapeutic target (CastroOchoa2018Hematopoietic; Liu2023Comprehensive).

## Structure
Hematopoietic cell-specific Lyn substrate 1 (HS1) is an actin-binding protein encoded by the HCLS1 gene, primarily expressed in hematopoietic cells. The HS1 protein consists of 486 amino acids and has a predicted molecular weight of approximately 54 kDa, although it appears as a 75 kDa protein in SDS-PAGE due to an acidic sequence motif affecting SDS binding (CastroOchoa2018Hematopoietic).

HS1 contains several functional domains: an N-terminal acidic (NTA) region that binds the Arp2/3 complex, a domain with 3.5 repeats of helix-turn-helix motifs, a coiled-coil domain for F-actin binding, a proline-rich domain (PRD) for binding SH2-domain-containing proteins, and a C-terminal SH3 domain for interactions with proteins like dynamin-2 and WIP (CastroOchoa2018Hematopoietic). The protein is structurally related to cortactin, suggesting a putative actin-binding domain at its N-terminus (Muzio2007HS1).

Post-translational modifications of HS1 include phosphorylation by spleen tyrosine kinase (Syk) on tyrosines 378 and 397, which creates docking sites for other signaling proteins (CastroOchoa2018Hematopoietic). These phosphorylations are crucial for its role in cellular signaling and interactions with other proteins involved in actin cytoskeletal dynamics (CastroOchoa2018Hematopoietic). The presence of splice variant isoforms of HS1 is suggested, potentially leading to different functional roles (Skokowa2012Interactions).

## Function
HCLS1, also known as hematopoietic cell-specific Lyn substrate 1, is an actin-binding protein primarily expressed in hematopoietic cells. It plays a critical role in regulating actin dynamics, which are essential for cellular processes such as adhesion, migration, phagocytosis, and granule release (CastroOchoa2018Hematopoietic). HCLS1 is a member of the class II nucleation-promoting factor family and interacts with the actin-related protein (Arp2/3) complex to stabilize branched actin networks (CastroOchoa2018Hematopoietic).

In T cells, HCLS1 is involved in T cell receptor (TCR) signaling, where it undergoes tyrosine phosphorylation and interacts with kinases like Lck, Fyn, and ZAP70, facilitating T cell activation and proliferation (CastroOchoa2018Hematopoietic). It also plays a role in B cell receptor (BCR) signaling, affecting B cell survival and activation through its phosphorylation and nuclear translocation (CastroOchoa2018Hematopoietic).

HCLS1 is crucial for the formation of lytic synapses in natural killer (NK) cells and is involved in actin remodeling and cell adhesion, with specific phosphorylations being essential for these processes (CastroOchoa2018Hematopoietic). In neutrophils, it is important for chemotaxis and recruitment to inflamed tissues, interacting with proteins like Vav1 and Arp2/3 to activate small GTPases such as Rac1 and Rap1 (CastroOchoa2018Hematopoietic).

## Clinical Significance
The HCLS1 gene, also known as HS1, is implicated in several diseases and conditions through mutations, changes in expression levels, or alterations in its interactions. In chronic lymphocytic leukemia (CLL), HS1 is overexpressed and hyperphosphorylated in patients with poor prognosis, correlating with shorter survival times (CastroOchoa2018Hematopoietic). In systemic lupus erythematosus (SLE), mutations in HS1, such as additional EP repeats or deletions in the actin-binding repeat, are linked to increased disease risk and altered B cell function (CastroOchoa2018Hematopoietic). In severe congenital neutropenia (SCN), HS1 is involved in myeloid differentiation and granulopoiesis, with its downregulation leading to reduced myelopoiesis (Younesian2023Genetics; CastroOchoa2018Hematopoietic). Mutations in HS1 can also lead to hyperproliferation in acute myeloid leukemia (CastroOchoa2018Hematopoietic). In lung adenocarcinoma (LUAD), low expression of HCLS1 is associated with advanced clinical stages and poor overall survival, suggesting its potential as a prognostic marker (Liu2023Comprehensive). Additionally, HCLS1 is overexpressed in a mouse model of Alzheimer's disease, indicating a possible role in its development (CastroOchoa2018Hematopoietic).

## Interactions
HCLS1, also known as HS1, is involved in various protein interactions that are crucial for its function in hematopoietic cells. It interacts with the actin-related protein (Arp2/3) complex, facilitating actin polymerization and stabilizing branched actin networks (CastroOchoa2018Hematopoietic). HS1 is phosphorylated by spleen tyrosine kinase (Syk) and interacts with signaling proteins such as Vav1 and Src family kinases, which are important for T cell receptor signaling and T cell activation (CastroOchoa2018Hematopoietic). In natural killer (NK) cells, HS1 is essential for actin remodeling and interacts with Vav1, which is important for transendothelial migration and chemotaxis (CastroOchoa2018Hematopoietic).

In B cells, HS1 undergoes tyrosine phosphorylation by Syk and Lyn kinases, which is crucial for its role in B-cell receptor signaling and apoptosis (CastroOchoa2018Hematopoietic). HS1 also interacts with proteins like cortactin and ZAP70, playing a role in actin remodeling in chronic lymphocytic leukemia (CastroOchoa2018Hematopoietic). Additionally, HS1 forms a multiprotein complex with Lyn in erythroid cells, suggesting its involvement in erythrocyte differentiation (CastroOchoa2018Hematopoietic). These interactions highlight HS1's role in actin dynamics and signal transduction in various immune cells.


## References


[1. (Muzio2007HS1) M Muzio, C Scielzo, M Frenquelli, A Bachi, M De Palma, M Alessio, P Ghia, and F Caligaris-Cappio. Hs1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia b cells. Leukemia, 21(9):2067–2070, May 2007. URL: http://dx.doi.org/10.1038/sj.leu.2404744, doi:10.1038/sj.leu.2404744. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.leu.2404744)

[2. (CastroOchoa2018Hematopoietic) Karla F Castro-Ochoa, Idaira M Guerrero-Fonseca, and Michael Schnoor. Hematopoietic cell-specific lyn substrate (hcls1 or hs1): a versatile actin-binding protein in leukocytes. Journal of Leukocyte Biology, 105(5):881–890, December 2018. URL: http://dx.doi.org/10.1002/jlb.mr0618-212r, doi:10.1002/jlb.mr0618-212r. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jlb.mr0618-212r)

[3. (Liu2023Comprehensive) Tingjun Liu, Ankang Hu, Hao Chen, Yan Li, Yonghui Wang, Yao Guo, Tingya Liu, Jie Zhou, Debao Li, and Quangang Chen. Comprehensive analysis identifies dna damage repair-related gene hcls1 associated with good prognosis in lung adenocarcinoma. Translational Cancer Research, 12(10):2613–2628, October 2023. URL: http://dx.doi.org/10.21037/tcr-23-921, doi:10.21037/tcr-23-921. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tcr-23-921)

[4. (Younesian2023Genetics) Samareh Younesian, Amir-Mohammad Yousefi, Peyman Eshghi, Mohammad Faranoush, Pooya Faranoush, Bijan Keikhaei, Aziz Eghbali, Bibi Shahin Shamsian, Babak Abdolkarimi, Sabahat Haghi, Hassan Abolghasemi, and Davood Bashash. Genetics and pathophysiology of severe congenital neutropenias (scns). Iranian Journal of Blood and Cancer, 15(2):146–171, June 2023. URL: http://dx.doi.org/10.58209/ijbc.15.2.146, doi:10.58209/ijbc.15.2.146. This article has 0 citations.](https://doi.org/10.58209/ijbc.15.2.146)

[5. (Skokowa2012Interactions) Julia Skokowa, Maxim Klimiankou, Olga Klimenkova, Dan Lan, Kshama Gupta, Kais Hussein, Esteban Carrizosa, Inna Kusnetsova, Zhixiong Li, Claudio Sustmann, Arnold Ganser, Cornelia Zeidler, Hans-Heinrich Kreipe, Janis Burkhardt, Rudolf Grosschedl, and Karl Welte. Interactions among hcls1, hax1 and lef-1 proteins are essential for g-csf–triggered granulopoiesis. Nature Medicine, 18(10):1550–1559, September 2012. URL: http://dx.doi.org/10.1038/nm.2958, doi:10.1038/nm.2958. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nm.2958)